CR4056

CAS No. 1004997-71-0

CR4056( CR 4056 | CR-4056 )

Catalog No. M10038 CAS No. 1004997-71-0

CR4056 (CR 4056, CR-4056) is a novel, orally active imidazoline-2 receptor (I2R) ligand with binding IC50 of 596 nM, also selectively inhibits the enzymatic activity of MAO-A with IC50 of 202.7 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 393 Get Quote
10MG 581 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG 1674 Get Quote
500MG 3348 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CR4056
  • Note
    Research use only, not for human use.
  • Brief Description
    CR4056 (CR 4056, CR-4056) is a novel, orally active imidazoline-2 receptor (I2R) ligand with binding IC50 of 596 nM, also selectively inhibits the enzymatic activity of MAO-A with IC50 of 202.7 nM.
  • Description
    CR4056 (CR 4056, CR-4056) is a novel, orally active imidazoline-2 receptor (I2R) ligand with binding IC50 of 596 nM, also selectively inhibits the enzymatic activity of MAO-A with IC50 of 202.7 nM; increases norepinephrine (NE) tissue levels both in the rat cerebral cortex and lumbar spinal cord, shows ED50 of 5.8 mg/kg in CFA rat model of inflammatory pain; shows high effectivity against bortezomib-induced painful neuropathy in rats.Pain Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CR 4056 | CR-4056
  • Pathway
    GPCR/G Protein
  • Target
    Imidazoline Receptor
  • Recptor
    Imidazoline Receptor
  • Research Area
    Neurological Disease
  • Indication
    Pain

Chemical Information

  • CAS Number
    1004997-71-0
  • Formula Weight
    272.311
  • Molecular Formula
    C17H12N4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1(C2=CC=CC=C2)=NC=C3C=C(N4C=CN=C4)C=CC3=N1
  • Chemical Name
    6-(1H-imidazol-1-yl)-2-phenylquinazoline

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ferrari F, et al. J Pain Res. 2011;4:111-25. 2. Thorn DA, et al. Br J Pharmacol. 2012 Jul;166(6):1936-45. 3. Meregalli C, et al. J Pain Res. 2012;5:151-67. 4. Lanza M, et al. Br J Pharmacol. 2014 Aug;171(15):3693-701.
molnova catalog
related products